UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031923
Receipt number R000036462
Scientific Title Study on the effects of dietary guidance on the thinning of the endometrium
Date of disclosure of the study information 2018/03/27
Last modified on 2023/03/30 14:52:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the effects of dietary guidance on the thinning of the endometrium

Acronym

Study on the effects of dietary guidance on the thinning of the endometrium

Scientific Title

Study on the effects of dietary guidance on the thinning of the endometrium

Scientific Title:Acronym

Study on the effects of dietary guidance on the thinning of the endometrium

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Study the effects of dietary guidance on the thinning of the endometrium.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Endometrial thickness

Key secondary outcomes

Presence / absence of pregnancy, equol production ability, subject background


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Dietary guidance

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Healthy Japanese who is 20 years old or more
3.Persons who' s endometrial in the implantation stage should is less than 10 mm
4.For those with normal luteal body function (blood estradiol > 100 pg / ml, progesterone > 10 mg / ml)

Key exclusion criteria

1.Persons who have chronic illness and are receiving medication
2.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam
3.Persons who were judged as inappropriate for subjects by the principal investigator

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akihiro Sakurai

Organization

Medical Corporation Obstetrics and gynecology clinic SACRA

Division name

President

Zip code


Address

2-9-3 Shin-ishikawa, Aoba-ku, Yokohama-shi, Kanagawa, JAPAN

TEL

045-911-9936

Email

ceo@cl-sacra.com


Public contact

Name of contact person

1st name
Middle name
Last name Akihiro Sakurai

Organization

Medical Corporation Obstetrics and gynecology clinic SACRA

Division name

President

Zip code


Address

2-9-3 Shin-ishikawa, Aoba-ku, Yokohama-shi, Kanagawa, JAPAN

TEL

045-911-9936

Homepage URL


Email

ceo@cl-sacra.com


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Healthcare Systems Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 03 Month 26 Day

Date of IRB

2018 Year 03 Month 26 Day

Anticipated trial start date

2018 Year 03 Month 28 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 27 Day

Last modified on

2023 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036462


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name